Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Other2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT06827587Not ApplicableNot Yet Recruiting
Efficacy and Safety of Efgartigimod Sequential Therapy with Telitacicept in Generalized Myasthenia Gravis
Autoimmune DiseasesMyasthenia GravisNeuromuscular Diseases
Principalinvestigator
NCT07159893Not ApplicableNot Yet Recruiting
Inectolizumab With Steroid Optimization in Newly Treated NMOSD
Autoimmune DiseasesDemyelinating Autoimmune Diseases, CNSNeuromyelitis Optica
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

First Affiliated Hospital of Wenzhou Medical University

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT06827587Not ApplicablePrincipalInvestigator

Efficacy and Safety of Efgartigimod Sequential Therapy with Telitacicept in Generalized Myasthenia Gravis

Autoimmune DiseasesMyasthenia GravisNeuromuscular Diseases
Not Yet Recruiting
NCT07159893Not ApplicablePrincipalInvestigator

Inectolizumab With Steroid Optimization in Newly Treated NMOSD

Autoimmune DiseasesDemyelinating Autoimmune Diseases, CNSNeuromyelitis Optica
Not Yet Recruiting

All 2 trials loaded